Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C)

被引:18
作者
Maxhimer, JB
Reddy, RM
Zuo, JT
Cole, GW
Schrump, DS
Nguyen, DM
机构
[1] NCI, Sect Thorac Oncol, Surg Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[2] Howard Hughes Med Inst, Natl Inst Hlth Res Scholar Program, Bethesda, MD 20817 USA
关键词
D O I
10.1016/j.jtcvs.2004.07.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Histone deacetylase inhibitors mediate a potent growth-inhibitory effect in cancer cells through induction of cell-cycle arrest and apoptosis. Moreover, these agents significantly induce transcriptional activation of nuclear factor kappaB, as well as p21 regulated by protein kinase C, and are thought to negatively influence the ability of histone deacetylase inhibitor to effectively mediate apoptosis. This study aimed to evaluate the effect of calphostin C (a protein kinase C inhibitor) on trichostatin A (a histone deacetylase inhibitor)-mediated upregulation of nuclear factor kappaB and p21 promotor transcriptional activity, as well as induction of apoptosis in lung and esophageal cancer cells. Methods: Cultured lung and esophageal cancer cells were treated with calphostin C and trichostatin A. Nuclear factor kappaB transcriptional activity was quantitated by using the nuclear factor kappaB-luciferase assay. Transcription of p2l gene and p21 protein levels was evaluated by using the p21 promoter-luciferase assay and the p21 enzyme-linked immunoassay, respectively. Apoptosis was evaluated by using the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-based ApoBrdU assay. Levels of expression of nuclear factor kappaB-dependent antiapoptotic and proapoptotic proteins were evaluated by means of Western blotting. Results: Exposure of lung or esophageal cancer cells to trichostatin A resulted in a dose- and cell-dependent 2-fold to greater than 20-fold increase of nuclear factor kappaB and p21 transcriptional activity. Treatment with trichostatin A and calphostin C led to a 50% to 90% decrease of trichostatin A- mediated upregulation of nuclear factor kappaB and p21 activation. Inhibition of nuclear factor kappaB activity resulted in significant reduction (30% to >99%) of trichostatin A- mediated activation of not only nuclear factor kappaB transcription but also p21 promotor activity. Importantly, 90% to 96% of thoracic cancer cells under-went apoptosis after exposure to the combination of trichostatin A plus calphostin C. Conclusion: Inhibition of protein kinase C abrogates trichostatin A-mediated upregulation of nuclear factor kappaB transcriptional activity and p21 expression that is associated with profound induction of apoptosis in lung or esophageal cancer cells. Protein kinase C might be a novel target for enhancing the efficacy of histone deacetylase inhibitor in cancer therapy.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 20 条
[11]   Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line [J].
Nakano, K ;
Mizuno, T ;
Sowa, Y ;
Orita, T ;
Yoshino, T ;
Okuyama, Y ;
Fujita, T ;
OhtaniFujita, N ;
Matsukawa, Y ;
Tokino, T ;
Yamagishi, H ;
Oka, T ;
Nomura, H ;
Sakai, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22199-22206
[12]   Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells [J].
Nguyen, DM ;
Schrump, WD ;
Chen, GA ;
Tsai, W ;
Nguyen, P ;
Trepel, JB ;
Schrump, DS .
CLINICAL CANCER RESEARCH, 2004, 10 (05) :1813-1825
[13]   Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling pathway [J].
Nguyen, DM ;
Schrump, WD ;
Tsai, WS ;
Chen, A ;
Stewart, JH ;
Steiner, F ;
Schrump, DS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (05) :1132-1142
[14]  
Rosato RR, 2003, CANCER RES, V63, P3637
[15]  
SHEPHERD FA, 1994, SEMIN ONCOL, V21, P7
[16]   Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation [J].
Shin, HJ ;
Baek, KH ;
Jeon, AH ;
Kim, SJ ;
Jang, KL ;
Sung, YC ;
Kim, CM ;
Lee, CW .
ONCOGENE, 2003, 22 (25) :3853-3858
[17]  
Spigel David R, 2003, Semin Surg Oncol, V21, P98, DOI 10.1002/ssu.10027
[18]   Histone deacetylase inhibitors in cancer treatment [J].
Vigushin, DM ;
Coombes, RC .
ANTI-CANCER DRUGS, 2002, 13 (01) :1-13
[19]   Induction of cIAP-2 in human colon cancer cells through PKCδ/NF-κB [J].
Wang, QD ;
Wang, XF ;
Evers, BM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) :51091-51099
[20]  
Yu XD, 2002, J NATL CANCER I, V94, P504